Inhibikase Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SANDS CAPITAL VENTURES, LLC | 05/08/2026 | 13.02 M | $21.87 M | 0.00% | 13.24% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 10.88 M | $18.27 M | 0.00% | 11.06% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 05/15/2026 | 8.63 M | $14.49 M | 0.00% | 8.77% |
| 05/15/2026 | 8.06 M | $13.54 M | 30.42% | 8.20% | |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 6.61 M | $11.10 M | -18.07% | 6.72% |
| BLACKROCK, INC. | 05/13/2026 | 6.30 M | $10.59 M | 90.69% | 6.41% |
| BLACKSTONE INC. | 05/15/2026 | 5.94 M | $9.98 M | 0.00% | 6.04% |
| SIREN, L.L.C. | 05/14/2026 | 5.85 M | $9.83 M | 0.00% | 5.95% |
| COMMODORE CAPITAL LP | 05/15/2026 | 5.40 M | $9.07 M | 0.00% | 5.49% |
| 05/15/2026 | 4.45 M | $7.48 M | 100.00% | 4.53% | |
| SATURN V CAPITAL MANAGEMENT LLC | 05/15/2026 | 3.86 M | $6.49 M | 0.17% | 3.93% |
| 05/15/2026 | 3.82 M | $6.42 M | 118.39% | 3.89% | |
| 05/14/2026 | 3.58 M | $6.02 M | 0.00% | 3.64% | |
| 05/15/2026 | 3.50 M | $5.88 M | -17.16% | 3.56% | |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 2.93 M | $4.92 M | 1,623.92% | 2.98% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.70 M | $4.54 M | -31.24% | 2.75% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 2.32 M | $3.89 M | -57.30% | 2.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.17 M | $3.65 M | 92.35% | 2.21% |
| STATE STREET CORP | 05/15/2026 | 1.69 M | $2.83 M | 203.83% | 1.71% |
| SUMMITTX CAPITAL, L.P. | 05/15/2026 | 1.52 M | $2.56 M | 100.00% | 1.55% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2026 | 1.35 M | $2.27 M | -22.86% | 1.37% |
| ALLY BRIDGE GROUP (NY) LLC | 05/18/2026 | 1.33 M | $2.23 M | 100.00% | 1.35% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.10 M | $1.85 M | -11.34% | 1.12% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 957.20 K | $1.61 M | -59.24% | 0.97% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 847.61 K | $1.42 M | 100.00% | 0.86% |
| NORTHERN TRUST CORP | 05/14/2026 | 718.80 K | $1.21 M | 122.73% | 0.73% |
| 05/08/2026 | 617.73 K | $1.04 M | 100.00% | 0.63% | |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 567.00 K | $952.56 K | 100.00% | 0.58% |
| NUVEEN, LLC | 04/30/2026 | 472.40 K | $793.63 K | 500.57% | 0.48% |
| JPMORGAN CHASE & CO | 05/13/2026 | 328.52 K | $519.06 K | 1,222.06% | 0.33% |
| 06/04/2026 | 325.60 K | $547.01 K | -38.99% | 0.33% | |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 322.70 K | $542.14 K | 595.32% | 0.33% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 235.41 K | $395.50 K | 54.57% | 0.24% |
| UBS GROUP AG | 05/05/2026 | 228.15 K | $383.29 K | 141.31% | 0.23% |
| RANGELEY CAPITAL, LLC | 05/15/2026 | 220.00 K | $369.60 K | 100.00% | 0.22% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 213.21 K | $358.19 K | 55.08% | 0.22% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 172.01 K | $288.98 K | 100.00% | 0.18% |
| MORGAN STANLEY | 05/15/2026 | 164.26 K | $275.96 K | 106.14% | 0.17% |
| BLAIR WILLIAM & CO/IL | 05/08/2026 | 157.99 K | $265.42 K | 3.29% | 0.16% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 149.86 K | $251.76 K | 75.75% | 0.15% |
| ALGERT GLOBAL LLC | 05/14/2026 | 133.83 K | $225.00 K | 100.00% | 0.14% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 122.44 K | $205.70 K | 122.99% | 0.12% |
| FMR LLC | 05/15/2026 | 71.96 K | $120.90 K | 25.43% | 0.07% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 05/14/2026 | 62.91 K | $105.69 K | 100.00% | 0.06% |
| RHUMBLINE ADVISERS | 05/12/2026 | 58.72 K | $98.64 K | 24.50% | 0.06% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 50.87 K | $86.00 K | 66.22% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2026 | 50.28 K | $84.48 K | 74.14% | 0.05% |
| SEI INVESTMENTS CO | 05/13/2026 | 47.96 K | $80.58 K | 100.00% | 0.05% |
| NEW YORK STATE COMMON RETIREMENT FUND | 05/06/2026 | 47.90 K | $80.47 K | 0.00% | 0.05% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 40.53 K | $68.09 K | -40.25% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibikase Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 106 institutional investors and hedge funds held shares of Inhibikase Therapeutics Inc. The most heavily invested institutionals were:
Sands Capital Ventures, LLC: 13.02 M
Soleus Capital Management, L.P.: 10.88 M
Fairmount Funds Management LLC: 8.63 M
ADAR1 Capital Management, LLC: 6.61 M
BlackRock, Inc.: 6.3 M
Blackstone Inc.: 5.94 M
115.95% of Inhibikase Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 95.44 M shares in the last 24 months. This purchase volume represents approximately $180.38 M in transactions.